发明名称 CONTROLLED ACTIVATION INGESTIBLE IDENTIFIER
摘要 Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.
申请公布号 US2015182463(A1) 申请公布日期 2015.07.02
申请号 US201414570673 申请日期 2014.12.15
申请人 Proteus Digital Health, Inc. 发明人 Hafezi Hooman;Robertson Timothy;Colliou Olivier;Zdeblick Mark
分类号 A61K9/20;A61B5/00 主分类号 A61K9/20
代理机构 代理人
主权项 1. A pharmaceutical composition comprising: a pharmaceutical active agent; a controlled activation identifier configured to transmit a signal upon contact with a target site of a body, wherein the controlled activation identifier comprises: a solid support;first and second materials with dissimilar electrochemical properties located on a surface of the solid support; anda dried conductive medium precursor; and a pharmaceutically acceptable carrier.
地址 Redwood City CA US